An ISO 9001:2008
COMPANY

Write to us on the following email id to get specific quote sales@veeprholabs.com

Everolimus Impurity

Veeprho Laboratories is a manufacturer and supplier of Everolimus impurities like Everolimus Impurity C (CAS No. 1062122-63-7), Everolimus Impurity D (Isomer 1 & 2) / Everolimus Retroaldol Degradation Product (CAS No. 1708118-13-1), Everolimus Impurity E / Ester hydrolysis degradant of IP D (CAS No. 147438-30-0) and TGR / Everolimus tert-Butyldimethylsilyl Ether Impurity (CAS No. 159351-68-5), Everolimus Process Impurity, Everolimus Degradation Impurity, Everolimus Impurity and Everolimus Potential Impurity. These impurities are provided with certificate of analysis along with the characterization data like NMR MASS IR and HPLC Purity. We also provide additional data like C NMR, CHN, TGA RF on request.


We are also manufacturer and supplier of all Everolimus USP, EP, BP pharmacopoeia impurities, any unknown impurity, APIs and intermediates with structure elucidation with help of C NMR, H NMR, MASS, CHN, HPLC data. On request we also manufacture and supply all impurity of Everolimus as per pharmacopoeia RRT.


We also manufacture and supply all Everolimus impurities which are to be isolated by preparative HPLC and Lyophilized.


All the Everolimus impurities like Everolimus Impurity C (CAS No. 1062122-63-7), Everolimus Impurity D (Isomer 1 & 2) / Everolimus Retroaldol Degradation Product (CAS No. 1708118-13-1), Everolimus Impurity E / Ester hydrolysis degradant of IP D (CAS No. 147438-30-0), TGR / Everolimus tert-Butyldimethylsilyl Ether Impurity (CAS No. 159351-68-5), Everolimus Process Impurity, Everolimus Degradation Impurity, Everolimus Impurity and Everolimus Potential Impurity etc. are manufactured and supplied by Veeprho Laboratories are acceptable to all regulatory agencies in the world like US-FDA, MHRA, MCC, WHO, Brazil and Japan.


These Everolimus impurities are also used for ANDA filling/DMF filling and genotoxic study.


Get a Quote
Write to us on the following email id to get specific quote sales@veeprholabs.com

Everolimus Impurities :-



Everolimus Impurity C
Everolimus Impurity C

(2S)-1-[2-Oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R, 19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-2-piperidinecarbo

Catalogue No : VL2280001

Everolimus Impurity D (Isomer 1 & 2) / Everolimus Retroaldol Degradation Product
Everolimus Impurity D (Isomer 1 & 2) / Everolimus Retroaldol Degradation Product

(S)-(2R,3S,6R,E)-1-((1S,3R,4R)-4-(2-Hydroxyethoxy)-3-methoxycyclohexyl)-2,6,8-trimethyl-5,9-dioxonon-7-en-3-yl 1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxotrideca-3,5,7-trien-1-yl)-2-hydroxy-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylate; E

Catalogue No : VL2280002

Everolimus Impurity E / Ester hydrolysis degradant of IP D
Everolimus Impurity E / Ester hydrolysis degradant of IP D

(2S)-1-[[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-Dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrienyl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]oxoacetyl]-2-piperidinecarboxylic Acid

Catalogue No : VL2280003

TGR / Everolimus tert-Butyldimethylsilyl Ether Impurity
TGR / Everolimus tert-Butyldimethylsilyl Ether Impurity

42-O-[2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]rapamycin; 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine Rapamycin Derivative

Catalogue No : VL2280004